Reuters logo
BRIEF-New Thrombogenics ophthalmic research findings presented at ARVO 2017
May 2, 2017 / 5:42 AM / 6 months ago

BRIEF-New Thrombogenics ophthalmic research findings presented at ARVO 2017

May 2 (Reuters) - Thrombogenics NV:

* New Thrombogenics ophthalmic research findings presented at ARVO 2017 annual vision research meeting in Baltimore

* Plans to initiate two further phase I/IIa clinical trials around year end and early 2018 with THR-687 and THR-149; expects to deliver first phase II data in H1 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below